Investor Presentation January 2022 slide image

Investor Presentation January 2022

A Global Leader in Myopia Management Broadest portfolio of science-based treatment options addressing the progression of myopia in children Ortho-k MiSight 1 day BRILLIANT FUTURES™ WITH MISIGHT 1 day Only FDA approved myopia control product CooperVision Specialty EyeCare Paragon CooperVision Specialty EyeCare CooperVision Procornea Specialty EyeCare GP Specialists Broad range of market- leading Ortho-k lenses SG SIGHTGLASS VISION Innovative myopia management spectacles Cooper Companies 10
View entire presentation